230 related articles for article (PubMed ID: 27903281)
1. Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers.
Dadas A; Washington J; Marchi N; Janigro D
Fluids Barriers CNS; 2016 Nov; 13(1):21. PubMed ID: 27903281
[TBL] [Abstract][Full Text] [Related]
2. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.
Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L
J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000
[TBL] [Abstract][Full Text] [Related]
3. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
[TBL] [Abstract][Full Text] [Related]
4. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
[TBL] [Abstract][Full Text] [Related]
5. Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects.
Mahan MY; Thorpe M; Ahmadi A; Abdallah T; Casey H; Sturtevant D; Judge-Yoakam S; Hoover C; Rafter D; Miner J; Richardson C; Samadani U
World Neurosurg; 2019 Aug; 128():e434-e444. PubMed ID: 31051301
[TBL] [Abstract][Full Text] [Related]
6. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
[TBL] [Abstract][Full Text] [Related]
7. Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial.
Korley F; Pauls Q; Yeatts SD; Jones CMC; Corbett-Valade E; Silbergleit R; Frankel M; Barsan W; Cahill ND; Bazarian JJ; Wright DW
J Neurotrauma; 2021 Jul; 38(14):1953-1960. PubMed ID: 33319651
[TBL] [Abstract][Full Text] [Related]
8. Stability of Blood Biomarkers of Traumatic Brain Injury.
Rezaii PG; Grant GA; Zeineh MM; Richardson KJ; Coburn ML; Bet AM; Weber A; Jiang B; Li Y; Ubungen K; Routh G; Wheatcroft AM; Paulino AD; Hayes RL; Steinberg GK; Wintermark M
J Neurotrauma; 2019 Aug; 36(16):2407-2416. PubMed ID: 30968744
[TBL] [Abstract][Full Text] [Related]
9. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.
Welch RD; Ayaz SI; Lewis LM; Unden J; Chen JY; Mika VH; Saville B; Tyndall JA; Nash M; Buki A; Barzo P; Hack D; Tortella FC; Schmid K; Hayes RL; Vossough A; Sweriduk ST; Bazarian JJ
J Neurotrauma; 2016 Jan; 33(2):203-14. PubMed ID: 26467555
[TBL] [Abstract][Full Text] [Related]
10. Prospective Assessment of Acute Blood Markers of Brain Injury in Sport-Related Concussion.
Meier TB; Nelson LD; Huber DL; Bazarian JJ; Hayes RL; McCrea MA
J Neurotrauma; 2017 Nov; 34(22):3134-3142. PubMed ID: 28699381
[TBL] [Abstract][Full Text] [Related]
11. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
[TBL] [Abstract][Full Text] [Related]
12. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
[TBL] [Abstract][Full Text] [Related]
13. Insight into Pre-Clinical Models of Traumatic Brain Injury Using Circulating Brain Damage Biomarkers: Operation Brain Trauma Therapy.
Mondello S; Shear DA; Bramlett HM; Dixon CE; Schmid KE; Dietrich WD; Wang KK; Hayes RL; Glushakova O; Catania M; Richieri SP; Povlishock JT; Tortella FC; Kochanek PM
J Neurotrauma; 2016 Mar; 33(6):595-605. PubMed ID: 26671651
[TBL] [Abstract][Full Text] [Related]
14. A Narrative Review of Existing and Developing Biomarkers in Acute Traumatic Brain Injury for Potential Military Deployed Use.
Kocik VI; Dengler BA; Rizzo JA; Ma Moran M; Willis AM; April MD; Schauer SG
Mil Med; 2024 May; 189(5-6):e1374-e1380. PubMed ID: 37995274
[TBL] [Abstract][Full Text] [Related]
15. Blood-Based Protein Biomarkers for the Management of Traumatic Brain Injuries in Adults Presenting to Emergency Departments with Mild Brain Injury: A Living Systematic Review and Meta-Analysis.
Mondello S; Sorinola A; Czeiter E; Vámos Z; Amrein K; Synnot A; Donoghue E; Sándor J; Wang KKW; Diaz-Arrastia R; Steyerberg EW; Menon DK; Maas AIR; Buki A
J Neurotrauma; 2021 Apr; 38(8):1086-1106. PubMed ID: 29020853
[TBL] [Abstract][Full Text] [Related]
16. Kinetic modelling of serum S100b after traumatic brain injury.
Ercole A; Thelin EP; Holst A; Bellander BM; Nelson DW
BMC Neurol; 2016 Jun; 16():93. PubMed ID: 27315805
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study".
Seidenfaden SC; Kjerulff JL; Juul N; Kirkegaard H; Møller MF; Münster AB; Bøtker MT
Scand J Trauma Resusc Emerg Med; 2021 Jun; 29(1):75. PubMed ID: 34078435
[TBL] [Abstract][Full Text] [Related]
18. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.
Bazarian JJ; Biberthaler P; Welch RD; Lewis LM; Barzo P; Bogner-Flatz V; Gunnar Brolinson P; Büki A; Chen JY; Christenson RH; Hack D; Huff JS; Johar S; Jordan JD; Leidel BA; Lindner T; Ludington E; Okonkwo DO; Ornato J; Peacock WF; Schmidt K; Tyndall JA; Vossough A; Jagoda AS
Lancet Neurol; 2018 Sep; 17(9):782-789. PubMed ID: 30054151
[TBL] [Abstract][Full Text] [Related]
19. Circulating GFAP and Iba-1 levels are associated with pathophysiological sequelae in the thalamus in a pig model of mild TBI.
Lafrenaye AD; Mondello S; Wang KK; Yang Z; Povlishock JT; Gorse K; Walker S; Hayes RL; Kochanek PM
Sci Rep; 2020 Aug; 10(1):13369. PubMed ID: 32770054
[TBL] [Abstract][Full Text] [Related]
20. Taking a Closer Look at the Biomarker Test for Mild Traumatic Brain Injury.
Voelker R
JAMA; 2018 May; 319(20):2066-2067. PubMed ID: 29800154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
